Peptide Drug Conjugates and Their Role in Cancer Therapy
Ethan Heh1, Jesse Allen1, Fabiola Ramirez1
1Paul L. Foster School of Medicine, Department of Medical Education, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA.
International Journal of Molecular Sciences
|January 8, 2023
Summary
Peptide-drug conjugates (PDCs) offer targeted cancer therapy with advantages over traditional treatments. Despite challenges like stability, PDCs remain a promising research area due to their specificity and smaller size.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Background:
- Drug conjugates are crucial for targeted cancer medicine.
- Peptide-drug conjugates (PDCs) utilize peptides, payloads, and linkers for drug delivery.
- PDCs include cell-penetrating peptides (CPPs) and cell-targeting peptides (CTPs).
Purpose of the Study:
- To review the advantages and disadvantages of peptide-drug conjugates (PDCs) in cancer treatment.
- To highlight the potential of PDCs as a targeted cancer therapy.
- To discuss challenges and modifications for PDCs.
Main Methods:
- Literature review of peptide-drug conjugate research.
- Comparison of PDCs with antibody-drug conjugates (ADCs) and traditional therapies.
- Analysis of PDC advantages, disadvantages, and potential modifications.
Main Results:
- PDCs offer better tumor penetration, easier synthesis, lower cost, and fewer off-target effects than ADCs.
- PDCs exhibit higher specificity and fewer side effects than chemotherapy or radiation.
- Disadvantages include poor stability and rapid clearance, impacting bioavailability.
Conclusions:
- PDCs represent an attractive area for cancer treatment research due to their specificity and size.
- Modifications can address challenges like stability and bioavailability.
- PDCs show significant promise for targeted cancer therapy.
Related Concept Videos
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
01:27Tumor Immunotherapy
621
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
621
01:14Phase II Conjugation Reactions: Overview
272
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
272
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.6K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.6K
02:50Conjugated Proteins
18.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K